ECCVID Abstract Submission Opening Soon!

Don’t miss the opportunity to submit your abstract for the ESCMID Conference on Coronavirus Disease, taking place online from 23 – 25 September 2020.

The call will open on the 20th July 2020 and run for 2 weeks, closing on 3 August 2020.

See the ESCMID Website for the abstract submission guidelines and template.

› Read more

Public consultation phase open for
three new guidance documents

Microbial Pathogenesis in Alzheimer’s Disease: research grants from IDSA

In order to identify a potential microbial link to Alzheimer’s disease, IDSA is offering up to ten (10), $100,000 research grants. All application submissions must be narrowly focused on elucidating the possible roles of infectious agents in the causation of Alzheimer’s disease. The awards will support innovative research including basic, clinical, and/or non-traditional approaches. International applications are welcome and you do not need to be a member of IDSA to apply!

› Read more

COVID-19 and One Health – Wednesday 8 July, 20:00 CEST

Join an international faculty for the upcoming live online webinar event 'COVID-19 and One Health: can we do better?', being hosted by the Federation of European Academies of Medicine and the Federation of Veterinarians of Europe.

ESCMID Emerging Infections Task Force (EITaF) Chairperson Eskild Petersen will join the conversation addressing SARS-CoV-2 as a zoonosis: the human health perspective.

The Webinar will take place on Wednesday, 8 July at 11:00 – 12:30 CEST.

View the Programme flyer here.

› Read more

GARDP Webinar: Antimicrobial R&D in low- and middle-income countries

Don’t miss the next GARDP Webinar, taking place on Thursday, 9 July at 09:00-10:30 CEST.

Join speakers Anand Anandkumar and Kamini Walia as they discuss the challenges facing, and opportunities arising for antimicrobial R&D in India.

Register on the GARDP Website. 

› Read more

Gilead COVID-19 Research Grant opportunity

Gilead has announced COMMIT™ (COvid-19 unMet MedIcal needs and associated research exTension) COVID-19 RFP program.

The COMMIT™ program will support well defined individual projects of no more than $250,000 USD or equivalent sum; projects that are more than $250,000 will require approval by Gilead prior to submission.

The full description of the program and the required forms can be found on the Gilead ISR website, here.

› Read more

CMI highlight: Childhood COVID-19: a multi-center retrospective study

Children are a special group with immature immune systems and respiratory systems, which make disease process and manifestation different from adults. This is also seen in the COVID-19 pandemic that has become prevalent all over the world, causing widespread concern. Chen et al. analysed the clinical data of 32 confirmed paediatric patients from 7 hospitals in Zhejiang province of eastern China to summarise clinical experiences in the diagnosis and treatment of paediatric COVID-19.

Early clinical investigations suggest that COVID-19 is predominantly prevalent in adults, with only a small percentage of paediatric patients, however the number of paediatric patients being reported is growing. The authors found that the majority of paediatric patients had at least one family members being a confirmed COVID-19 patient. Overall most of the children had mild symptoms with a good prognosis. However, viral RNA duration was much longer than clinical symptoms, specifically gastrointestinal samples had a very long duration. The authors conclude that while prognosis is generally better, more attention should be paid to household contact history investigation in the diagnosis of COVID-19 in young children.

› Read more